These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33523340)

  • 21. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
    Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Nishiwada S; Cui Y; Sho M; Jun E; Akahori T; Nakamura K; Sonohara F; Yamada S; Fujii T; Han IW; Tsai S; Kodera Y; Park JO; Von Hoff D; Kim SC; Li W; Goel A
    Ann Surg; 2022 Dec; 276(6):e876-e885. PubMed ID: 34132691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer.
    Sahu D; Lin CC; Goel A
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.
    Zhou L; Li SH; Wu Y; Xin L
    Cancer Med; 2021 May; 10(10):3309-3322. PubMed ID: 33934516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
    Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
    Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
    Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
    Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
    Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
    Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting gastric cancer recurrence using biomarker gene expression.
    Jeong SH; Kim RB; Park SY; Park J; Jung EJ; Ju YT; Jeong CY; Park M; Ko GH; Song DH; Koh HM; Kim WH; Yang HK; Lee YJ; Hong SC
    Eur J Surg Oncol; 2020 Jan; 46(1):195-201. PubMed ID: 31564475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
    Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
    Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.